NanoSphere Closes $2million Private Placement Offering

DENVER (February 21, 2019)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it has closed its second and final tranche of its non-brokered private placement announced on Feb. 11, 2019. Pursuant to the first tranche, the company issued 6,666,394 units at a price of 30 cents per unit for gross proceeds of $1,999,918.20.

Read More
Samuel TheilComment
NanoSphere Signs Definitive Licensing Agreement in Oregon

Partnership with Cascade Pure Brings Disruptive Evolve Formulas Technology to $550 Million Oregon Cannabis Market

DENVER (Feb. 20, 2019)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“NanoSphere” or “the Company”) is pleased to announce the signing of a definitive Licensing Agreement with Oregon cannabis company Cascade Pure, LLC. The Agreement gives Cascade Pure the exclusive right to produce and distribute Evolve Formulas products in the State of Oregon.

Read More
Samuel TheilComment
The Cannabis Company That Really DELIVERS

As the cannabis industry matures, both the opportunities and the challenges in this new sector are starting to crystallize. But what is a “challenge” for the cannabis industry as a whole can spell opportunity for individual companies. Perhaps no niche of the industry illustrates this point better than cannabis delivery technology.

Read More
Samuel TheilComment
NanoSphere Receives First Export Order for CBD Hemp Products From Abba Imports in Mexico

DENVER--(BUSINESS WIRE)--NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“NanoSphere” or “the Company”) has for the first time received an order to export its patented Evolve Formulas CBD Hemp transdermal NanoSerum™.

The initial order is for 60,000 units of the Company’s Evolve Formulas CBD Hemp transdermal NanoSerum™. The order comes from Abba Import Export S.A. de C.V. (Abba), one of the premiere distributors of health and wellness products in Mexico. Abba is a large supplier for the top retailers in the country, including the top national pharmacy and grocery chains, Walmart, Sam’s Club, and Costco.

Read More
Samuel TheilComment
Game-Changing NanoSphere Products Soon to Disrupt the Oklahoma Cannabis Market

—NanoSphere Health Sciences Signs Memorandum of Understanding with 4Evergrn —

DENVER (February 5, 2019)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF, the biotechnology leader behind the patented NanoSphere Delivery System™, today signed a new letter of intent with  4Evergrn LLC,  which will bring Evolve Formulas products to the Oklahoma medical and recreational cannabis markets. The brand’s pioneering product, the Evolve Formulas Transdermal NanoSerum™, will hit dispensary shelves in the third quarter of 2019.

Read More
Samuel TheilComment
NanoSphere Partners with Gofire to Debut DoseCode-Enabled Products in Colorado Market

—Scannable Technology Grants Patients Access to Descriptions, Reviews and Dosing Information for Evolve Formulas Products—

DENVER (December 6, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today announced the launch of its new, DoseCode-enabled Evolve Formulas products in the Colorado market, leveraging industry-first technology from Denver-based healthcare startup Gofire.

Read More
Samuel TheilComment
Nanosphere Closes $1.335m First Tranche of Private Placement

DENVER (December 14, 2018) – NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce a first tranche closing of its non-brokered private placement announced November 28, 2018.  Pursuant to the first tranche, the company issued 4,452,254 Units at a price of $0.30 per Unit for gross proceeds of CAD $1,335,676. 

Read More
Samuel TheilComment
NanoSphere Health Sciences Form Strategic Partnership to Launch Evolve Products in Mexico

Agreement will bring the patented NanoSphere Delivery System™ to a
$5 billion market.

VANCOUVER (Dec. 10, 2018)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“NanoSphere” or “the Company”), the biotechnology leader behind the patented
NanoSphere Delivery System™, is pleased to announce the Company has signed a Letter of Intent forming a partnership with Abba Import Export S.A. de C.V., to launch Evolve’s growing product line in Mexico.

Read More
Samuel TheilComment
NanoSphere Announces Revised Terms for Private Placement

DENVER--(BUSINESS WIRE)--NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF) announces revised terms for its non-brokered private placement previously announced on Nov. 16, 2018. The offering will consist of up to 7,500,000 units at a price of $0.30 per unit for gross proceeds of up to CAD $2,250,000. Each unit will be comprised of a common share and a full purchase warrant exercisable to purchase a further common share at a price of $0.50 cents for a period of 24 months, subject to accelerated expiry if the Company’s shares trade at or above $0.75 for 15 consecutive days.

Read More
Samuel TheilComment
Nanosphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line

DENVER (November 16, 2018)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) is pleased to announce a non-brokered private placement of up to CAD $2,250,000. The proceeds will be used to expand our award-winning Evolve Formulas cannabis products into more markets in the US, Canada, and outside of North America.  Funds will also be used to develop new products, increase production in the states that Evolve Products are available in, as well as for general working capital.

Read More
Samuel TheilComment
Game-Changing Evolve Formulas Products Soon to Disrupt the Oregon Cannabis Market

—NanoSphere Health Sciences Signs Letter of Intent with Cascade Pure—

DENVER (November 13, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today signed a new letter of intent with Cascade Pure, LLC, which will bring Evolve Formulas products to the Oregon medical and recreational cannabis markets. The brand’s pioneering product, the Evolve Formulas Transdermal NanoSerum™, will hit dispensary shelves in the first quarter of 2019.

Read More
Samuel TheilComment
Evolve Formulas Transdermal NanoSerum™ CBD Met with Unprecedented Response Across Colorado Market

—Industry-First Formulation Harnesses the Anti-Inflammatory Qualities of CBD and Antioxidant Power of Resveratrol for Maximum Wellness Benefits—

DENVER (November 7, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today announced the expansion of its CBD-dominant product—the Evolve Formulas Transdermal NanoSerum™ CBD with Resveratrol—across Colorado due to considerable public demand. The company has already moved more than 1,000 units in the market in less than a month.

Read More
Samuel TheilComment
NanoSphere Health Sciences and Vertical Companies™ Commence Production in California

Award-Winning Evolve Formulas Transdermal NanoSerum™ To Hit Dispensary Shelves in the Golden State in Time for the Holidays

DENVER (October 10, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, in partnership with Vertical™, the largest fully integrated company in the legal medical cannabis industry, has officially started production to bring its commercial cannabis brand, Evolve Formulas, into the California market.

Read More
Samuel TheilComment
THE COMPLEX RELATIONSHIP BETWEEN CANNABIS AND MENTAL HEALTH

By Dr. Michele Ross

As the national dialogue surrounding cannabis continues to shift in favor of legalization, public knowledge of the plant’s health and wellness benefits is spreading, with many patients of mental illness discovering the potential of cannabis to relieve psychological distress and restore their ability to function in day-to-day life.

Read More
Samuel Theil